(Q90566673)

PubMed ID

32199889

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

title

Should biologics for psoriasis be interrupted in the era of COVID-19? (English)

1 reference

PubMed ID

32199889

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

1 reference

Mark Lebwohl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Ryan Rivera-Oyola

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Dedee F Murrell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

publication date

18 March 2020

1 reference

PubMed ID

32199889

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

page(s)

1217-1218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

The IL-12 family of cytokines in infection, inflammation and autoimmune disorders

27 May 2020

cites work

1 reference

12 December 2020

Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept

1 reference

12 December 2020

Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension

1 reference

12 December 2020

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis.

1 reference

12 December 2020

10.1016/J.JAAD.2020.03.031

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 May 2020

COVIDWHO ID

covidwho-11728

0 references

1125763929

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32199889%20AND%20SRC:MED&resulttype=core&format=json